Cancer Informatics in 2019: Deep Learning Takes Center Stage

Summary

Objective: To summarize significant research contributions on cancer informatics published in 2019.

Methods: An extensive search using PubMed/Medline and manual review was conducted to identify the scientific contributions published in 2019 that address topics in cancer informatics. The selection process comprised three steps: (i) 15 candidate best papers were first selected by the two section editors, (ii) external reviewers from internationally renowned research teams reviewed each candidate best paper, and (iii) the final selection of two best papers was conducted by the editorial committee of the Yearbook.

Results: The two selected best papers demonstrate the clinical utility of deep learning in two important cancer domains: radiology and pathology.

Conclusion: Cancer informatics is a broad and vigorous subfield of biomedical informatics. Applications of new and emerging computational technologies are especially notable in 2019.

Keywords

Neoplasms - informatics - health information technology - deep learning - ethics

• References

• 1 Griffin AC, Topaloglu U, Davis S, Chung AE. From patient engagement to precision oncology: leveraging informatics to advance cancer care. Yearb Med Inform 2020; xxx.xxx
• 2 Lamy JB, Séroussi B, Griffon N, Kerdelhué G, Jaulent MC, Bouaud J. Toward a formalization of the process to select IMIA Yearbook best papers. Methods Inf Med 2015; 54 (02) 135-44
• 3 National Academies of Sciences. Improving Cancer Diagnosis and Care: Clinical Application of Computational Methods in Precision Oncology: Proceedings of a Workshop [Internet]. 2019 [cited 2020 May 23]. Available from: https://www.nap.edu/catalog/25404/improving-cancer-diagnosis-and-care-clinical-application-of-computational-methods
• 4 Ardila D, Kiraly AP, Bharadwaj S, Choi B, Reicher JJ, Peng L. et al End-to-end lung cancer screening with three-dimensional deep learning on low-dose chest computed tomography. Nat Med 2019; May; 25: 954-61
• 5 The National Lung Screening Trial: Overview and Study Design1. Radiology 2011; Jan; 258 (01) 243-53
• 6 Okereke IC, Nishi S, Zhou J, Goodwin JS. Trends in lung cancer screening in the United States, 2016–2017. J Thorac Dis 2019; Mar; 11 (03) 873-81
• 7 Campanella G, Hanna MG, Geneslaw L, Miraflor A, Werneck Krauss Silva V. et al Clinical-grade computational pathology using weakly supervised deep learning on whole slide images. Nat Med 2019; 25: 1301-1309
• 8 Ornstein C, Thomas K. Sloan Kettering’s Cozy Deal With Start-Up Ignites a New Uproar. The New York Times [Internet]. 2018 Sep 20 [cited 2020 May 23]; Available from: https://www.nytimes.com/2018/09/20/health/memorial-sloan-kettering-cancer-paige-ai.html
• 9 Huang Y, Han L, Dou H, Luo H, Yuan Z, Liu Q. et al Two-stage CNNs for computerized BI-RADS categorization in breast ultrasound images. BioMed Eng OnLine 2019; 18: 8
• 10 Wong NC, Lam C, Patterson L, Shayegan B. Use of machine learning to predict early biochemical recurrence after robot-assisted prostatectomy. BJU Int 2019; 123 (01) 51-7
• 11 McKinney SM, Sieniek M, Godbole V, Godwin J, Antropova N, Ashrafian H. et al International evaluation of an AI system for breast cancer screening. Nature 2020; 577: 89-94
• 12 Banerjee I, Bozkurt S, Caswell-Jin JL, Kurian AW, Rubin DL. Natural language processing approaches to detect the timeline of metastatic recurrence of breast cancer. JCO Clin Cancer Inform 2019 Oct;3:1-12.
• 13 Warner JL, Dymshyts D, Reich CG, Gurley MJ, Hochheiser H, Moldwin ZH. et al HemOnc: A new standard vocabulary for chemotherapy regimen representation in the OMOP common data model. J Biomed Inform 2019; 96: 103239
• 14 Xu Y, Kong S, Cheung WY, Bouchard-Fortier A, Dort JC, Quan H. et al Development and validation of case-finding algorithms for recurrence fo breast cancer using routinely collected administrative data. BMC Cancer 2019; 19: 210
• 15 Wu S, Meng J, Yu Q, Li P, Fu S. Radiomics-based machine learning methods for isocitrate dehydrogenase genotype prediction of diffuse gliomas. J Can Res Clin Oncol 2019; 145: 543-50
• 16 Kocak B, Durmaz ES, Ates E, Ulusan MB. Radiogenomics in Clear Cell Renal Cell Carcinoma: Machine Learning–Based High-Dimensional Quantitative CT Texture Analysis in Predicting PBRM1 Mutation Status. AJR Am J Roentgenol 2019; 212 (03) W55-W63
• 17 Bernard J, Sessler D, Kohlhammer J, Ruddle RA. Using dashboard networks to visualize multiple patient histories: a design study on post-operative prostate cancer. IEEE Trans Vis Comput Graph 2019; 25 (03) 1615-28
• 18 Lin L, Liang W, Li CF, Huang XD, Lv JW, Peng H. et al Development and implementation of a dynamically updated big data intelligence platform from electronic health records for nasopharyngeal carcinoma research. Br J Radiol 2019; 92: 20190255
• 19 Zuley ML, Nishikawa RM, Lee CS, Burnside E, Rosenberg R, Sickles EA. et al. Linkage of the ACR National Mammography Database to the Network of State Cancer Registries: Proof of Concept Evaluation by the ACR National Mammography Database Committee. J Am Coll Radiol 2019; Jan; 16 (01) 8-14
• 20 Maguire FB, Morris CR, Parikh-Patel A, Cress RD, Keegan THM, Li CS. , et al. A text-mining approach to obtain detailed treatment information from free-text fields in population-based cancer registries: A study of non-small cell lung cancer in California. PLoS ONE 2019; 14 (02) e0212454
• 21 National Mammography Database [Internet]. [cited 2020 May 23]. Available from: https://www.acr.org/Practice-Management-Quality-Informatics/Registries/National-Mammography-Database
• 22 Lever J, Zhao EY, Grewal J, Jones MR, Jones SJM. CancerMine: a literature-mined resource for drivers, oncogenes and tumor suppressors in cancer. Nat Methods 2019; 16: 505-7
• 23 Zhu VJ, Lenert LA, Bunnell BE, Obeid JS, Jefferson M, Hughes-Halbert CA. Automatically identifying social isolation from clinical narratives for patients with prostate cancer. BMC Med Inform Dec Making 2019; 19: 43